CompletedNot applicableNCT02505308
Defining the Molecular and Physiological Mechanisms of Pancreatic Islet Cell Dysfunction Which Lead to Type 2 Diabetes
Studying Rare diabetes mellitus type 2
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Royal Devon and Exeter NHS Foundation Trust
- Principal Investigator
- Timothy M Frayling (Prof), PhDUniversity of Exeter
- Intervention
- Glucose-Potentiated Arginine-Induced Insulin Secretion(other)
- Enrollment
- 328 enrolled
- Eligibility
- 16-75 years · All sexes
- Timeline
- 2015 – 2019
Study locations (2)
- University of Exeter, Exeter, Devon, United Kingdom
- University of Oxford, Oxford, Oxfordshire, United Kingdom
Collaborators
University of Exeter · University of Oxford · Oxford University Hospitals NHS Trust
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02505308 on ClinicalTrials.govOther trials for Rare diabetes mellitus type 2
Additional recruiting or active studies for the same condition.